Metastatic Renal Cell Carcinoma
Retrospective and prospective study in mRCC patients treated with sutent in first line and rechallenged by Sutent in 3rd and 4th line.
AzTrials uses cookies for analytics and advertising. You can accept or reject them; the site works either way. Privacy Policy.
Free account
You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.